Mevalonic acid

Mevalonic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 10134 references associated with Mevalonic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Mevalonic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Mevalonic acid

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Body Weight D001835 333 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypothyroidism D007037 32 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Per page 10 20 50 | Total 25

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with Mevalonic acid

Download all related citations
Per page 10 20 50 100 | Total 2899
Authors Title Published Journal PubMed Link
Loregger A et al. Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis. 2017 Arterioscler. Thromb. Vasc. Biol. pmid:28882874
Yamashita Y et al. A 6-year-old girl diagnosed with mevalonate kinase deficiency who had hydrops fetalis and neonatal-onset cholestasis. 2017 Nihon Rinsho Meneki Gakkai Kaishi pmid:28603204
Ye L et al. Type IIs restriction based combinatory modulation technique for metabolic pathway optimization. 2017 Microb. Cell Fact. pmid:28302121
Agabiti SS et al. Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation. 2017 Cell Death Dis pmid:28300835
Kuzuyama T Biosynthetic studies on terpenoids produced by Streptomyces. 2017 J. Antibiot. pmid:28196976
Cheng T et al. Enzymatic process optimization for the in vitro production of isoprene from mevalonate. 2017 Microb. Cell Fact. pmid:28068985
Kosek V et al. High resolution mass spectrometry based method applicable for a wide range of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors in blood serum including intermediates and products of the cholesterol biosynthetic pathway. 2017 J Chromatogr A pmid:28209347
Ding Y et al. Gamma-tocotrienol reverses multidrug resistance of breast cancer cells with a mechanism distinct from that of atorvastatin. 2017 J. Steroid Biochem. Mol. Biol. pmid:27864002
Tricarico PM et al. 25-Hydroxycholesterol and inflammation in Lovastatin-deregulated mevalonate pathway. 2017 Int. J. Biochem. Cell Biol. pmid:28918367
Montero-Villegas S et al. Inhibition of Mevalonate Pathway and Synthesis of the Storage Lipids in Human Liver-Derived and Non-liver Cell Lines by Lippia alba Essential Oils. 2017 Lipids pmid:27905068